Table 1 Patient characteristics and treatment at initial presentation
Characteristics | Patients | |
|---|---|---|
Number | Percent | |
Age, median (range) | 55.5 (19–79) | |
Sex | ||
 Female | 18 | 60% |
 Male | 12 | 40% |
Ann Arbor Stage | ||
 I/II | 11 | 36.7% |
 III/IV | 19 | 63.3% |
Extranodal involvement | ||
 Yes | 23 | 76.7% |
 No | 7 | 23.3% |
Bulky disease, cm | ||
 ≥ 7.5 | 14 | 46.7% |
 < 7.5 | 16 | 53.3% |
Histology | ||
 DLBCL-NOS | 20 | 66.7% |
 Primary mediastinal B-cell lymphoma | 6 | 20% |
 Transformed DLBCL | 2 | 6.7% |
 High-grade B-cell lymphoma | 1 | 3.3% |
 Primary breast B-cell lymphoma | 1 | 3.3% |
Initial systemic regimen | ||
 R-CHOP | 26 | 86.7% |
 DA-EPOCH-R | 4 | 13.3% |